Cystic Fibrosis and Periodontal Diseases
NCT06133335 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2023-11-15
Summary
The number of CF adults is increasing year after year (61.7% in 2021) confirming that patients are living longer. These data do not leave aside the desire to see CF patients "age well" considering of all the comorbidities linked to aging.
Among these comorbidities, the oral repercussions of cystic fibrosis and its treatments remain to this day little investigated. We know, however, that oral health, and periodontal health, is closely linked to general health. Indeed, the oral cavity presents one of the richest microbiota in the body, made up of bacteria, viruses, yeasts and archae organized into a biofilm at the interface of periodontal tissues. Periodontal diseases are partly linked to an imbalance in and loss of diversity within the commensal periodontal flora, aggravated by risk factors such as diabetes, which affects many CF adults. Early detection and treatment of periodontal diseases are therefore of primary interest in patients at increased risk of respiratory infections such as CF patients. This transversal research project aims to study the oral repercussions, notably periodontal disease prevalence in cystic fibrosis (CF) adult patients.
Thus, this program will allow, on the one hand, the acquisition of clinical and biological data on periodontal and/or dental pathologies from which adult CF patients may suffer. These data will be accessible through an oral and periodontal clinical examination that will allow the identification of diagnostic clues. The quality of life related to oral health will also be investigated using a self-administered questionnaire. Clinical and biological data commonly recorded in the context of the medical follow-up of CF patients (ventilatory capacity, glycemic status, cytobacteriological examination of sputum, etc.) will also be taken into account in order to study any correlations with periodontal status.
On the other hand, on a more fundamental level, this work aims to investigate the impact of CFTR protein dysfunction on the local immunity of the oral cavity and more particularly on the expression of antimicrobial peptides at the level of the periodontium.
Thus this project is articulated around a strong axis which is "aging well" for adult CF patients thanks to the improvement of knowledge and ultimately the prevention of comorbidities linked to aging in CF adult patients and particularly those related to oral health.
Conditions
- Cystic Fibrosis
- Periodontitis
- Gingivitis
Interventions
- OTHER
-
Periodontal examination
Periodontal examination is performed using PCP UNC15 periodontal probe (common diagnostic method not added by research). Gingival smear from various points in the oral cavity. This intervention consists in a smear of gingival area with an absorbent paper point into the space between the gum and the tooth (Jourdain et al. 2018). The objective of this technique is to remove the various elements of the periodontal pocket and in particular the desquamated cells.
Sponsors & Collaborators
-
CHU de Reims
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-07-20
- Primary Completion
- 2025-01-20
- Completion
- 2025-01-20
Countries
- France
Study Locations
More Related Trials
-
Clinical Course and Changes in the Respiratory Microbiota Based on Antibiotic Treatment in Patients With Cystic Fibrosis
NCT01693965 ·Status: COMPLETED ·Phase: NA
-
Nasal Mucin Oral Supplementation Treatment Respiratory Inflammation Using PUFA in Cystic Fibrosis (CF) Patients
NCT01329172 ·Status: TERMINATED ·Phase: NA
-
Gynecological Health Improvement of Adult Women With Cystic Fibrosis
NCT03892304 ·Status: COMPLETED
-
Contraceptive Practices and Cervical Screening in Women With Cystic Fibrosis
NCT02847208 ·Status: COMPLETED
-
Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients.
NCT03312075 ·Status: TERMINATED
-
Prevalence and Impact of Depression and Anxiety in Cystic Fibrosis
NCT03424486 ·Status: COMPLETED
-
Pregnancies and Cystic Fibrosis
NCT03290144 ·Status: UNKNOWN
-
COVID-19 Antibody Responses in Cystic Fibrosis
NCT05614336 ·Status: COMPLETED ·Phase: NA
-
Gut Imaging for Function & Transit in Cystic Fibrosis Study 1
NCT03566550 ·Status: COMPLETED
-
Pharmacokinetics of Polymyxin B in Adult Patients With Cystic Fibrosis
NCT04335370 ·Status: COMPLETED
-
Extrapulmonary Effects of Cystic Fibrosis on Physical Activity of Adult Patients.
NCT01848392 ·Status: COMPLETED
-
Breath Analysis in in Adults With Cystic Fibrosis (CF)
NCT02209571 ·Status: COMPLETED ·Phase: NA
-
Non-respiratory Comorbidities Observed in Pulmonary French Transplant Patients With Cystic Fibrosis
NCT03357913 ·Status: COMPLETED
-
Covid-19 Antibody Responses in Cystic Fibrosis
NCT05012306 ·Status: ACTIVE_NOT_RECRUITING
-
Microbial Biomarkers of EArly Pseudomonas Aeruginosa Colonization in CHildren With Cystic Fibrosis
NCT03947957 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Patienthèque of Finisterian (South of Brittany) Children With Cystic Fibrosis in the Time of Precision Medicine
NCT04137133 ·Status: RECRUITING ·Phase: NA
-
Cefiderocol Pharmacokinetics in Adult Patients With Cystic Fibrosis
NCT05314764 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Immunonutrition on the Patients With Cystic Fibrosis
NCT02048592 ·Status: UNKNOWN ·Phase: PHASE4
-
Intestinal Inflammation in CF Patients
NCT04392544 ·Status: ACTIVE_NOT_RECRUITING
-
Development a Core Set for Adults With Cystic Fibrosis Based on the ICF
NCT06128499 ·Status: COMPLETED
-
Physical Activity Profile and Sedentary Behaviour in Adults With Cystic Fibrosis
NCT06507956 ·Status: RECRUITING
-
Epidemiology of Anaerobic Bacteria in Cystic Fibrosis Patients: Descriptive and Non-interventional Study
NCT04879381 ·Status: COMPLETED
-
Performance and Patient Acceptance of a Commercially Available Beverage as Compared to an Oral Glucose Solution for Oral Glucose Tolerance Tests in Cystic Fibrosis (CF) Patients Who Are Screened for CF-related Diabetes.
NCT05377502 ·Status: UNKNOWN
-
The Use of Breath Volatile Organic Compounds in Early Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis
NCT05944367 ·Status: COMPLETED
-
A Pilot Study of a Low Glycemic Load Diet in Adults With Cystic Fibrosis
NCT04519853 ·Status: COMPLETED ·Phase: NA